Vietnam is steadily expanding access to renal replacement therapies as chronic kidney disease (CKD) becomes an increasingly significant public health challenge. While haemodialysis continues to dominate treatment, peritoneal dialysis is attracting growing attention for its ability to deliver effective, patient-centred care in the home.
Although no standalone valuation has been published for Vietnam's peritoneal dialysis market, industry analysis estimates the sector is currently worth US$60–75 million in 2025 and is projected to reach US$78–98 million by 2030.
Peritoneal dialysis is a home-based renal replacement therapy that uses the patient's peritoneal membrane as a natural filter to remove waste products and excess fluid. Compared with conventional in-centre haemodialysis, it offers greater flexibility, fewer hospital visits and improved quality of life for many patients.
The market includes:
- Continuous Ambulatory Peritoneal Dialysis (CAPD)
- Automated Peritoneal Dialysis (APD)
- Dialysis cyclers
- Dialysis solutions
- Peritoneal catheters
- Transfer sets
- Home dialysis consumables
- Remote monitoring platforms
- Clinical support services
Several long-term trends are driving market growth across Vietnam:
- Rising incidence of chronic kidney disease and diabetes.
- An ageing population requiring renal replacement therapy.
- Growing adoption of home-based healthcare.
- Increasing healthcare investment in nephrology services.
- Greater awareness of patient-centred treatment options.
- Expansion of remote patient monitoring technologies.
- Government initiatives to improve access to renal care.
According to IMARC Group, Vietnam's Dialysis Market reached US$503.8 million in 2025 and is forecast to grow to US$717.9 million by 2034. The market encompasses both haemodialysis and peritoneal dialysis and is being driven by expanding reimbursement policies, earlier diagnosis of kidney disease and increasing demand for renal replacement therapies.
Globally, interest in peritoneal dialysis continues to increase as healthcare systems seek more sustainable and patient-friendly models of care. IMARC Group estimates the Global Peritoneal Dialysis Market reached US$18.8 billion in 2025 and is expected to grow to US$27.0 billion by 2034. Home-based dialysis is becoming increasingly attractive because it reduces pressure on dialysis centres, lowers healthcare costs and allows patients greater independence.
Technology is helping accelerate this transition. Modern automated peritoneal dialysis systems now feature touchscreen interfaces, cloud connectivity and remote patient monitoring that allow clinicians to track treatment adherence and patient outcomes without requiring frequent hospital visits. Artificial intelligence is also beginning to support personalised dialysis prescriptions and early identification of complications, while digital monitoring platforms improve clinical oversight of home-based patients. Recent academic research highlights advances in computational modelling that are enabling more personalised peritoneal dialysis therapies and improving treatment optimisation.
The increasing emphasis on home dialysis also aligns with broader healthcare trends across Vietnam, where hospitals are seeking to improve capacity utilisation while delivering care closer to patients' homes. Expansion of nephrology services, improvements in chronic disease management and continued investment in healthcare infrastructure are expected to support long-term demand for peritoneal dialysis technologies.
Leading manufacturers operating in the global market include Baxter International, Fresenius Medical Care, B. Braun, Nipro, Terumo, Medtronic, Merit Medical Systems, Poly Medicure, Medical Components Inc. and Utah Medical Products, all of which continue to develop next-generation dialysis equipment, consumables and digital patient management solutions.
As Vietnam continues to modernise renal care and expand access to home-based therapies, peritoneal dialysis is expected to become an increasingly important component of chronic kidney disease management. For manufacturers of dialysis equipment, consumables, remote monitoring technologies and home healthcare solutions, Vietnam represents an attractive long-term growth opportunity within Southeast Asia.